(Q42104165)

16 October 2017

0 references

Small-cell prostate carcinoma: A retrospective analysis of five newly reported cases (English)

1 reference

16 October 2017

1 reference

2

Joseph Renzulli

1 reference

16 October 2017

Kyle R Brownback

1

1 reference

16 October 2017

Ronald Delellis

series ordinal

3

1 reference

16 October 2017

James R Myers

series ordinal

4

1 reference

16 October 2017

1 April 2009

1 reference

Indian Journal of Urology

16 October 2017

1 reference

16 October 2017

25

1 reference

16 October 2017

2

1 reference

16 October 2017

259-263

1 reference

Experience of the treatment with gemcitabine, docetaxel, and carboplatin (GDC) chemotherapy for patients with small-cell carcinoma of the prostate.

16 October 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Small-cell neuroendocrine carcinoma as a variant form of prostate cancer recurrence: a case report and short literature review

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Small cell carcinoma of the prostate: an immunohistochemical study.

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Molecular characterization of prostatic small-cell neuroendocrine carcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Neuroendocrine differentiation in human prostate tissue: is it detectable and treatable?

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Results of a phase II study with doxorubicin, etoposide, and cisplatin in patients with fully characterized small-cell carcinoma of the prostate

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Diagnosing and treating small-cell carcinomas of prostatic origin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Neuroendocrine differentiation in prostatic carcinoma

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Small Cell Anaplastic Carcinoma of the Prostate: Seven New Cases, Review of the Literature, and Discussion of a Therapeutic Strategy

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Neuroendocrine differentiation and hormone-refractory prostate cancer

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Small cell carcinoma of the bladder and prostate

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Prostate cancer with small-cell morphology: an immunophenotypic subdivision

29 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Neuroendocrine differentiation in carcinomas of the prostate: do neuroendocrine serum markers reflect immunohistochemical findings?

17 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2710081

Neuroendocrine differentiation in prostatic carcinoma during hormonal treatment

17 August 2018

1 reference

12 December 2020

Prostatic small-cell neuroendocrine carcinoma with disease progression monitored by measurement of serum progastrin-releasing peptide

1 reference

12 December 2020

Small cell carcinoma of the prostate. Part I. A clinicopathologic study of 20 cases

1 reference

12 December 2020

Large Cell Neuroendocrine Carcinoma of Prostate

1 reference

12 December 2020

Progression of prostate cancer to neuroendocrine cell tumor

1 reference

12 December 2020

Oral estramustine and oral etoposide for hormone-refractory prostate cancer

1 reference

12 December 2020

Use of neuroendocrine serum markers in the follow-up of patients with cancer of the prostate

1 reference

12 December 2020

Relapsed prostate cancer with neuroendocrine differentiation and high serum levels of carcinoembryonic antigen without elevation of prostrate-specific antigen: a case report

1 reference

12 December 2020

Identifiers

DOI

10.4103/0970-1591.52940

1 reference

16 October 2017

1 reference

16 October 2017

PubMed publication ID

19672363

1 reference